What sector does Haleos Labs Limited belong to?

Haleos Labs Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of HALEOSLABS?

As of the latest available quote, HALEOSLABS traded at ₹1,462.50. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of HALEOSLABS?

Haleos Labs Limited has a price-to-earnings (P/E) ratio of about 28.01. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of HALEOSLABS?

The market capitalisation of Haleos Labs Limited is approximately ₹442 Cr.

Is Haleos Labs Limited profitable?

For its latest reported financial year, Haleos Labs Limited recorded a net profit margin of about 5.39%.

Does HALEOSLABS pay a dividend?

Haleos Labs Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of HALEOSLABS?

Haleos Labs Limited has a return on equity (ROE) of about 8.44%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of HALEOSLABS?

Over the past 52 weeks, HALEOSLABS has traded between a low of ₹1,091.10 and a high of ₹1,774.00.

Haleos Labs Limited

HALEOSLABS NSE Healthcare Pharmaceuticals

₹1,462.50

+0.82%

Delayed · cached 15 min

Fair value analysis

HALEOSLABS

Haleos Labs Limited

₹1,450.60

Close used for this calculation

₹1,641.98Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

36/100

Profitability15/25

Returns9/25

Balance Sheet6/25

Efficiency6/25

Growth11/25

Average

Quality radar

Consensus fair value

₹1,641.98

Near FV

▲ +13.2% against the close used

Model range ₹389.81 – ₹3,052.17

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹389.81Fair value₹1,641.98Bull₹3,052.17

FairClose

52-week traded range

52W low ₹1,118.9052W high ₹1,690.10

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Haleos Labs Limited closed at ₹1,450.60, 11.7% below the consensus fair value of ₹1,641.98 drawn from 9 valuation models.

Financial DNA score 36/100 — Average. P/E of 28.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹1,136.55

-21.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹907.36

-37.4%

√(22.5 × EPS × BVPS)

EPS=57.26, BVPS=639.03 · outside Graham range (P/E 28, P/B 2.3) — asset-light, treat as a rough floor

Graham Formula

₹2,015.14

+38.9%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=14.7%, FD=7%

P/E Fair Value

₹2,044.18

+40.9%

EPS × 35.7x (sector P/E)

EPS=57.26, Sector P/E=35.7x

Peter Lynch (PEG)

₹841.72

-42.0%

EPS × Growth% (PEG = 1 is fair)

EPS=57.26, g=14.7%

EV/EBITDA

₹3,052.17

+110.4%

(EBITDA × 17.4x − Net Debt) ÷ Shares

EBITDA=600M

Book Value (P/B)

₹389.81

-73.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=639.03, ROE=8.4%, g=6%, r=10%

Reverse DCF

₹1,450.60

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 10.3% | Historical: 14.7%

Margin of Safety

₹1,144.36

-21.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1525.81, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer